Show Summary Details
Page of

Psychopharmacology for Sleep Paralysis 

Psychopharmacology for Sleep Paralysis
Psychopharmacology for Sleep Paralysis

Brian A. Sharpless

and Karl Doghramji

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 07 August 2020

Medications have not been developed specifically for the management of sleep paralysis. However, a variety of medications that are utilized to treat other disorders that are associated with sleep paralysis have, in turn, been observed to be of potential benefit in the reduction of sleep paralysis symptoms. Clinical cases are presented, which emphasize the role of management of the comorbid conditions in the definitive management of sleep paralysis. The possible role of direct management of sleep paralysis with various pharmacological agents is also explored, with a delineation of selected clinical considerations in the selection of an agent.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.